“…One of the reason for this is that the genetic event leading to the production of a H chain disease protein probably occurs at the mature B cell stage (48), whereas in transgenic mice the ⌬V protein is expressed at an early stage, which is more likely to induce tolerance (49). In addition, in contrast to numerous in vitro findings showing that mature spleen B cells can be stimulated to proliferate after stimulation with anti-IgM, cross-linking of BCR on mature B cells in vivo induces cell death (18,43,50), and the factors that determine, in the absence of T cells, the outcome of the responses induced by BCR ligation, namely tolerance, proliferation, or differentiation to the B1 cell subset (51), remain to be elucidated.…”